| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/2009 | CN100457112C Combination of medication of containing kurarinone and glycyrrhetic acid, and application |
| 02/04/2009 | CN100457096C An elemene formulation and preparation method thereof |
| 02/04/2009 | CN100457094C Preparing process of biodegradable capsule loading medicine and nano magnetic particle |
| 02/04/2009 | CN100457093C Chinese medicinal preparation for treating liver cancer, hepatitis B cirrhosis and preventing liver fibrillation and preparation thereof |
| 02/04/2009 | CN100457089C Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100457086C Aseptic medicine composition |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 02/03/2009 | US7485698 Administering a polypeptide as an antitumor or anticarcinogenic agent; (giant cell) glioblastoma, gliosarcoma; anaplastic astrocytoma, oligodendroglioma, ganglioglioma or ependymoma; medulloepithelioma, ependymoblastoma, medulloblastoma, and other brain cancers; side effect reduction |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485664 Inhibitors of TACE |
| 02/03/2009 | US7485659 Anticancer compositions, and methods of making and using the same |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485645 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485422 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485296 Using monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis and treatment of cell proliferfative disorders; immunodiagnostics; immunotherapy |
| 02/03/2009 | US7485292 Administering echovirus which recognizes integrin alpha 2 beta 1 for infectivity of the cells such that at least one of the cells are killed by the virus, wherein the abnormal cell is a cancer cell expressing alpha 2 beta 1; screening viruses |
| 02/03/2009 | US7485290 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 02/03/2009 | CA2478302C 9-aminoacridine derivatives and process for the preparation thereof |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2323150C New porphyrins and their use |
| 02/03/2009 | CA2314607C Use of ppar-.gamma. activators in dermatology |
| 02/03/2009 | CA2301082C Anti-cancer compounds |
| 02/03/2009 | CA2286165C A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/03/2009 | CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 02/03/2009 | CA1341590C Human immune interferon |
| 01/30/2009 | CA2712022A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 01/30/2009 | CA2595671A1 Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, hiv, aids and autoimmune diseases |
| 01/29/2009 | WO2009015368A2 Multikinase inhibitors for use in the treatment of cancer |
| 01/29/2009 | WO2009015363A1 Zearalenone macrolide derivatives and uses of the same |
| 01/29/2009 | WO2009015254A1 Triazine kinase inhibitors |
| 01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
| 01/29/2009 | WO2009014708A2 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 01/29/2009 | WO2009014702A2 Cd74 for use in the treatment of cancer and liver toxicity |
| 01/29/2009 | WO2009014642A1 Combination of a de novo purine biosynthesis inhibitor and a cyclin dependent kinase inhibitor for the treatment of cancer |
| 01/29/2009 | WO2009014450A1 Novel peptides with anti-tumor activity |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009014101A1 Novel sulfonated sugar derivative, and use thereof for medicinal agent |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009013901A1 Novel compound, method for production of the compound, pharmaceutical composition, anti-tumor agent, and use of the compound |
| 01/29/2009 | WO2009013619A2 The ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 01/29/2009 | WO2009013569A1 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 01/29/2009 | WO2009013358A2 Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions |
| 01/29/2009 | WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 01/29/2009 | WO2009013305A1 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 01/29/2009 | WO2009013126A1 Substituted indazole derivatives active as kinase inhibitors |
| 01/29/2009 | WO2009012785A2 Complexes of an emulgator and a fatty acid |
| 01/29/2009 | WO2009012784A2 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 01/29/2009 | WO2009012702A1 Use of 4-aniline quinazoline derivative for preparing medicaments |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2008149225A3 Anti-tumour vaccine comprising full-length wt1 |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008131575A3 Anti-alk antibodies suitable for treating metastatic cancers or tumors |
| 01/29/2009 | WO2008109368A4 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
| 01/29/2009 | WO2008101469A3 Pharmaceutical preparation for treating metastases |
| 01/29/2009 | WO2008075201A3 Epigallocatechin-3-gallate compositions for cancer therapy and chemoprotection |
| 01/29/2009 | WO2008020180A3 Methods of increasing the sensitivity of cancer cells to dna damage |
| 01/29/2009 | WO2008010101A9 Antagonist antibody against epha2 for the treatment of cancer |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | US20090030209 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-Acetoxy-2-benzoyloxy-5,20-epoxy-1,13-dihydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-6,11-diene; antitumor compounds; using low toxic and inexpensive materials; product is readily purified; industrial production |
| 01/29/2009 | US20090030088 Therapeutic benefits of gossypol, 6-methoxy gossypol, and 6,6'-dimothxy gossypol |
| 01/29/2009 | US20090030073 Plant-derived therapeutic agent for malignant |
| 01/29/2009 | US20090030068 Antitumour Compounds |
| 01/29/2009 | US20090030067 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane |
| 01/29/2009 | US20090030058 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 01/29/2009 | US20090030056 Novel sodium channel blockers |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030044 Crystal of Salt of Benzimidazole Compound |
| 01/29/2009 | US20090030031 Method of Preferentially Inducing the Biosynthesis of Interferon |
| 01/29/2009 | US20090030030 Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| 01/29/2009 | US20090030028 Tetrahydroquinolines |
| 01/29/2009 | US20090030027 Androgen Receptor Modulator Compounds and Methods |
| 01/29/2009 | US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof |
| 01/29/2009 | US20090030020 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors |
| 01/29/2009 | US20090030019 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 01/29/2009 | US20090030016 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 01/29/2009 | US20090030009 Heterobicyclic Carboxamides as Inhibitors for Kinases |
| 01/29/2009 | US20090030005 Combinations for the treatment of cancer |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029999 Synephrine derivatives useful as anti-inflammatory agents |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029992 Substituted pyrazole compounds |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029988 Hydroxyalkyl Substituted Imidazoquinolines |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029982 Protein kinase inhibitors |
| 01/29/2009 | US20090029975 1,3-benzothiazinone derivative and use thereof |
| 01/29/2009 | US20090029974 Tumor Treatment with Gliotoxin Derivatives |
| 01/29/2009 | US20090029973 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
| 01/29/2009 | US20090029972 Dibenzodiazepinone Analogues, Processes for Their Production and Their Use as Pharmaceuticals |
| 01/29/2009 | US20090029969 1-(2,4-dichlorophenyl)-4-methyl-5-(5-(pent-1-enyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; cannabinoid receptor modulator; liver fibrosis, obesity, type II diabetes, atherosclerosis, analgesia, haemorrhagic shock, ischemia, liver cirrhosis, neurodegenerative diseases |
| 01/29/2009 | US20090029968 Quinazoline derivatives used as inhibitors of erbb tyrosine kinase |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |